Genistein attenuates cancer stem cell characteristics in gastric cancer through the downregulation of Gli1

Dayeon Yu, Hyun Soo Shin, Yeo Song Lee, Doyeon Lee, Shin Kim, Yongchan Lee

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

Genistein is an isoflavone from soy with multiple action targets in cellular processes. Hedgehog signaling and its activator Gli1 are involved not only in oncogenesis, but also in cancer stemness and overexpression of CD44, a typical cancer stem cell surface marker. It has been shown that levels of Gli1 and CD44 expression are downregulated by genistein. Genistein may modulate distinctive cellular characteristics in cancer stem cells by inhibiting Gli1-related signaling pathways. In the present study, we sorted cells from MKN45, a human gastric cancer cell line, according to CD44 expression. CD44(+) cells showed properties of cancer stem-like cells and formed sphere colonies. In addition, sonic hedgehog (Shh) signaling genes were upregulated in CD44(+) cells when compared with these levels in CD44(-) cells. When CD44(+) cancer stem-like cells were treated with genistein, Gli1 and CD44 mRNA and protein expression was significantly reduced. Moreover, other stem cell markers were downregulated by genistein. Gli1 siRNA was used to confirm the action of genistein in inhibiting Gli1 expression. The high cell migration capacity of CD44(+) cells was blocked by genistein. In conclusion, genistein inhibits Gli1 gene expression, resulting in the attenuation of cancer stem-like properties in gastric cancer cells. In addition, genistein suppresses the cell invasive capacity that is required for tumor growth and metastasis. Our data showed that genistein can be an effective agent for gastric cancer therapy by targeting cancer stem-like characteristics.

Original languageEnglish
Pages (from-to)673-678
Number of pages6
JournalOncology Reports
Volume31
Issue number2
DOIs
Publication statusPublished - 2014 Feb 1

Fingerprint

Neoplastic Stem Cells
Genistein
Stomach Neoplasms
Down-Regulation
Neoplasms
Isoflavones
Small Interfering RNA
Cell Movement
Carcinogenesis
Stem Cells
Neoplasm Metastasis
Gene Expression
Cell Line
Messenger RNA

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research

Cite this

Yu, Dayeon ; Shin, Hyun Soo ; Lee, Yeo Song ; Lee, Doyeon ; Kim, Shin ; Lee, Yongchan. / Genistein attenuates cancer stem cell characteristics in gastric cancer through the downregulation of Gli1. In: Oncology Reports. 2014 ; Vol. 31, No. 2. pp. 673-678.
@article{391fd9a23fd04a81b4d4bcb1b935cc22,
title = "Genistein attenuates cancer stem cell characteristics in gastric cancer through the downregulation of Gli1",
abstract = "Genistein is an isoflavone from soy with multiple action targets in cellular processes. Hedgehog signaling and its activator Gli1 are involved not only in oncogenesis, but also in cancer stemness and overexpression of CD44, a typical cancer stem cell surface marker. It has been shown that levels of Gli1 and CD44 expression are downregulated by genistein. Genistein may modulate distinctive cellular characteristics in cancer stem cells by inhibiting Gli1-related signaling pathways. In the present study, we sorted cells from MKN45, a human gastric cancer cell line, according to CD44 expression. CD44(+) cells showed properties of cancer stem-like cells and formed sphere colonies. In addition, sonic hedgehog (Shh) signaling genes were upregulated in CD44(+) cells when compared with these levels in CD44(-) cells. When CD44(+) cancer stem-like cells were treated with genistein, Gli1 and CD44 mRNA and protein expression was significantly reduced. Moreover, other stem cell markers were downregulated by genistein. Gli1 siRNA was used to confirm the action of genistein in inhibiting Gli1 expression. The high cell migration capacity of CD44(+) cells was blocked by genistein. In conclusion, genistein inhibits Gli1 gene expression, resulting in the attenuation of cancer stem-like properties in gastric cancer cells. In addition, genistein suppresses the cell invasive capacity that is required for tumor growth and metastasis. Our data showed that genistein can be an effective agent for gastric cancer therapy by targeting cancer stem-like characteristics.",
author = "Dayeon Yu and Shin, {Hyun Soo} and Lee, {Yeo Song} and Doyeon Lee and Shin Kim and Yongchan Lee",
year = "2014",
month = "2",
day = "1",
doi = "10.3892/or.2013.2893",
language = "English",
volume = "31",
pages = "673--678",
journal = "Oncology Reports",
issn = "1021-335X",
publisher = "Spandidos Publications",
number = "2",

}

Genistein attenuates cancer stem cell characteristics in gastric cancer through the downregulation of Gli1. / Yu, Dayeon; Shin, Hyun Soo; Lee, Yeo Song; Lee, Doyeon; Kim, Shin; Lee, Yongchan.

In: Oncology Reports, Vol. 31, No. 2, 01.02.2014, p. 673-678.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Genistein attenuates cancer stem cell characteristics in gastric cancer through the downregulation of Gli1

AU - Yu, Dayeon

AU - Shin, Hyun Soo

AU - Lee, Yeo Song

AU - Lee, Doyeon

AU - Kim, Shin

AU - Lee, Yongchan

PY - 2014/2/1

Y1 - 2014/2/1

N2 - Genistein is an isoflavone from soy with multiple action targets in cellular processes. Hedgehog signaling and its activator Gli1 are involved not only in oncogenesis, but also in cancer stemness and overexpression of CD44, a typical cancer stem cell surface marker. It has been shown that levels of Gli1 and CD44 expression are downregulated by genistein. Genistein may modulate distinctive cellular characteristics in cancer stem cells by inhibiting Gli1-related signaling pathways. In the present study, we sorted cells from MKN45, a human gastric cancer cell line, according to CD44 expression. CD44(+) cells showed properties of cancer stem-like cells and formed sphere colonies. In addition, sonic hedgehog (Shh) signaling genes were upregulated in CD44(+) cells when compared with these levels in CD44(-) cells. When CD44(+) cancer stem-like cells were treated with genistein, Gli1 and CD44 mRNA and protein expression was significantly reduced. Moreover, other stem cell markers were downregulated by genistein. Gli1 siRNA was used to confirm the action of genistein in inhibiting Gli1 expression. The high cell migration capacity of CD44(+) cells was blocked by genistein. In conclusion, genistein inhibits Gli1 gene expression, resulting in the attenuation of cancer stem-like properties in gastric cancer cells. In addition, genistein suppresses the cell invasive capacity that is required for tumor growth and metastasis. Our data showed that genistein can be an effective agent for gastric cancer therapy by targeting cancer stem-like characteristics.

AB - Genistein is an isoflavone from soy with multiple action targets in cellular processes. Hedgehog signaling and its activator Gli1 are involved not only in oncogenesis, but also in cancer stemness and overexpression of CD44, a typical cancer stem cell surface marker. It has been shown that levels of Gli1 and CD44 expression are downregulated by genistein. Genistein may modulate distinctive cellular characteristics in cancer stem cells by inhibiting Gli1-related signaling pathways. In the present study, we sorted cells from MKN45, a human gastric cancer cell line, according to CD44 expression. CD44(+) cells showed properties of cancer stem-like cells and formed sphere colonies. In addition, sonic hedgehog (Shh) signaling genes were upregulated in CD44(+) cells when compared with these levels in CD44(-) cells. When CD44(+) cancer stem-like cells were treated with genistein, Gli1 and CD44 mRNA and protein expression was significantly reduced. Moreover, other stem cell markers were downregulated by genistein. Gli1 siRNA was used to confirm the action of genistein in inhibiting Gli1 expression. The high cell migration capacity of CD44(+) cells was blocked by genistein. In conclusion, genistein inhibits Gli1 gene expression, resulting in the attenuation of cancer stem-like properties in gastric cancer cells. In addition, genistein suppresses the cell invasive capacity that is required for tumor growth and metastasis. Our data showed that genistein can be an effective agent for gastric cancer therapy by targeting cancer stem-like characteristics.

UR - http://www.scopus.com/inward/record.url?scp=84892410753&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84892410753&partnerID=8YFLogxK

U2 - 10.3892/or.2013.2893

DO - 10.3892/or.2013.2893

M3 - Article

VL - 31

SP - 673

EP - 678

JO - Oncology Reports

JF - Oncology Reports

SN - 1021-335X

IS - 2

ER -